readthroughSign in
CompanyHROWNasdaqNashville, TN

Harrow Inc

Harrow develops ophthalmic medications and products for dry eye disease, age-related macular degeneration, cataracts, refractive errors, glaucoma, and other front and back-of-eye conditions.

8-KNov 16Latest SEC filing
Nov 9Latest story